Literature DB >> 17475222

Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products.

Shishir Shishodia1, Gautam Sethi, Kwang Seok Ahn, Bharat B Aggarwal.   

Abstract

Guggulsterone is a plant polyphenol traditionally used to treat obesity, diabetes, hyperlipidemia, atherosclerosis, and osteoarthritis, possibly through an anti-inflammatory mechanism. Whether this steroid has any role in cancer is not known. In this study, we found that guggulsterone inhibits the proliferation of wide variety of human tumor cell types including leukemia, head and neck carcinoma, multiple myeloma, lung carcinoma, melanoma, breast carcinoma, and ovarian carcinoma. Guggulsterone also inhibited the proliferation of drug-resistant cancer cells (e.g., gleevac-resistant leukemia, dexamethasone-resistant multiple myeloma, and doxorubicin-resistant breast cancer cells). Guggulsterone suppressed the proliferation of cells through inhibition of DNA synthesis, producing cell cycle arrest in S-phase, and this arrest correlated with a decrease in the levels of cyclin D1 and cdc2 and a concomitant increase in the levels of cyclin-dependent kinase inhibitor p21 and p27. Guggulsterone-induced apoptosis as indicated by increase in the number of Annexin V- and TUNEL-positive cells, through the downregulation of anti-apoptototic products. The apoptosis induced by guggulsterone was also indicated by the activation of caspase-8, bid cleavage, cytochrome c release, caspase-9 activation, caspase-3 activation, and PARP cleavage. The apoptotic effects of guggulsterone were preceded by activation of JNK and downregulation of Akt activity. JNK was needed for guggulsterone-induced apoptosis, inasmuch as inhibition of JNK by pharmacological inhibitors or by genetic deletion of MKK4 (activator of JNK) abolished the activity. Overall, our results indicate that guggulsterone can inhibit cell proliferation and induce apoptosis through the activation of JNK, suppression of Akt, and downregulation of antiapoptotic protein expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475222      PMCID: PMC2744036          DOI: 10.1016/j.bcp.2007.03.026

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  52 in total

Review 1.  GUGULIPID: a natural cholesterol-lowering agent.

Authors:  Nancy L Urizar; David D Moore
Journal:  Annu Rev Nutr       Date:  2003-02-26       Impact factor: 11.848

2.  Guggulsterone: an old approach to a new problem.

Authors:  Christopher J Sinal; Frank J Gonzalez
Journal:  Trends Endocrinol Metab       Date:  2002-09       Impact factor: 12.015

Review 3.  Development of therapeutics: opportunities within complementary and alternative medicine.

Authors:  Linda W Engel; Stephen E Straus
Journal:  Nat Rev Drug Discov       Date:  2002-03       Impact factor: 84.694

4.  Inhibition of LPS-induced NO production by the oleogum resin of Commiphora wightii and its constituents.

Authors:  Meselhy R Meselhy
Journal:  Phytochemistry       Date:  2003-01       Impact factor: 4.072

5.  Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning.

Authors:  L Zhu; S Fukuda; G Cordis; D K Das; N Maulik
Journal:  FEBS Lett       Date:  2001-11-23       Impact factor: 4.124

6.  c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.

Authors:  Claire Vivo; Weihong Liu; V Courtney Broaddus
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

7.  Signaling and function of caspase and c-jun N-terminal kinase in cisplatin-induced apoptosis.

Authors:  Myoung-Sook Koo; Young-Guen Kwo; Joon-Hong Park; Won-Jin Choi; Timothy R Billiar; Young-Myeong Kim
Journal:  Mol Cells       Date:  2002-04-30       Impact factor: 5.034

8.  The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcomes study.

Authors:  Betsy B Singh; Lakshmi C Mishra; Sivarama Prasad Vinjamury; Nanette Aquilina; Vijay J Singh; Neil Shepard
Journal:  Altern Ther Health Med       Date:  2003 May-Jun       Impact factor: 1.305

9.  Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2.

Authors:  Salvatore Papa; Francesca Zazzeroni; Concetta Bubici; Shanthi Jayawardena; Kellean Alvarez; Shuji Matsuda; Dung U Nguyen; Can G Pham; Andreas H Nelsbach; Tiziana Melis; Enrico De Smaele; Wei-Jen Tang; Luciano D'Adamio; Guido Franzoso
Journal:  Nat Cell Biol       Date:  2004-01-25       Impact factor: 28.824

10.  A JNK-dependent pathway is required for TNFalpha-induced apoptosis.

Authors:  Yibin Deng; Xiaoyang Ren; Lin Yang; Yahong Lin; Xiangwei Wu
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

View more
  36 in total

1.  Induction of apoptosis and cell cycle arrest in human HCC MHCC97H cells with Chrysanthemum indicum extract.

Authors:  Zong-Fang Li; Zhi-Dong Wang; Yuan-Yuan Ji; Shu Zhang; Chen Huang; Jun Li; Xian-Ming Xia
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

2.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

Review 3.  Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals.

Authors:  Subash C Gupta; Ji Hye Kim; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

4.  Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway.

Authors:  Juan-Juan Shi; Xiao-Li Jia; Mei Li; Ning Yang; Ya-Ping Li; Xin Zhang; Ning Gao; Shuang-Suo Dang
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

5.  Proteomic analysis of rosiglitazone and guggulsterone treated 3T3-L1 preadipocytes.

Authors:  Pooja Pal; Jitendra K Kanaujiya; Savita Lochab; Shashi B Tripathi; Sabyasachi Sanyal; Gerhard Behre; Arun K Trivedi
Journal:  Mol Cell Biochem       Date:  2012-12-30       Impact factor: 3.396

6.  Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Kwang S Ahn; Preetha Anand; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

7.  Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Authors:  Rebecca J Leeman-Neill; Sarah E Wheeler; Shivendra V Singh; Sufi M Thomas; Raja R Seethala; Daniel B Neill; Mary C Panahandeh; Eun-Ryeong Hahm; Sonali C Joyce; Malabika Sen; Quan Cai; Maria L Freilino; Changyou Li; Daniel E Johnson; Jennifer R Grandis
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

8.  Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts.

Authors:  Baoxiang Guan; Hao Li; Zhengduo Yang; Ashraful Hoque; Xiaochun Xu
Journal:  Cancer       Date:  2012-12-20       Impact factor: 6.860

9.  Guggulsterone modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in SENCAR mice.

Authors:  Sami Sarfaraz; Imtiaz A Siddiqui; Deeba N Syed; Farrukh Afaq; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2008-08-05       Impact factor: 4.944

10.  Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death.

Authors:  Changyou Li; Yan Zang; Malabika Sen; Rebecca J Leeman-Neill; David S K Man; Jennifer R Grandis; Daniel E Johnson
Journal:  Mol Cancer Ther       Date:  2009-07-28       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.